
At WATT AI, we are helping clients build a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.

WATT AI's ML-driven platform integrates in vitro cellular data produced in our labs with human clinical data to help redefine disease. Engineered to accelerate the development of new medicines, our platform precisely identifies therapeutic insights and interventions across a wide spectrum of diseases.

We generate multi-modal phenotypic cellular data in our automated laboratories and aggregate clinical data from human cohorts. We use these data to fuel machine learning and generative AI to build and interrogate phenotypic models of disease state. We leverage human genetics to identify causal intervention points in disease and turn them into effective therapeutic interventions in the right patients.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.